沛嘉医疗-B(09996)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

09996 沛嘉医疗-B

已收盘 09-19 16:08:11

2.890

-0.170

-5.56%

最高3.050	最低2.800	成交量396.96万
今开2.930	昨收3.060	日振幅8.17%
总市值19.63亿	流通市值19.63亿	总股本6.79亿
成交额1,143万	换手率0.58%	流通股本6.79亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"09996","market":"HK","secType":"STK","nameCN":"沛嘉医疗-B","latestPrice":2.89,"timestamp":1726733291021,"preClose":3.06,"halted":0,"volume":3969622,"delay":0,"floatShares":679326808,"shares":679326808,"eps":-0.6365433,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.17,"latestTime":"09-19 16:08:11","open":2.93,"high":3.05,"low":2.8,"amount":11426561,"amplitude":0.081699,"askPrice":2.9,"askSize":1000,"bidPrice":2.89,"bidSize":9000,"shortable":0,"etf":0,"ttmEps":-0.40764423595987315,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1726795800000},"adr":0,"listingDate":1589472000000,"adjPreClose":3.06,"openAndCloseTimeList":[[1726709400000,1726718400000],[1726722000000,1726732800000]],"volumeRatio":2.564223,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/09996/tweets","defaultTab":"tweets","newsList":[{"id":"2468575421","title":"1000亿灰飞烟灭，医疗器械巨头，被资本狠狠抛弃！","url":"https://stock-news.laohu8.com/highlight/detail?id=2468575421","media":"市值观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468575421?lang=zh_cn&edition=full","pubTime":"2024-09-19 20:03","pubTimestamp":1726747380,"startTime":"0","endTime":"0","summary":"2022年8月，中国第二大医疗器械巨头联影医疗登陆科创板，当年市值最高突破1770亿。疫情期间，联影医疗CT、MR业务快速膨胀，带动整体业务大幅增长。CT市场占有率从2019年的7.8%大幅飙升至2023年的23.5%，超越西门子医疗和飞利浦，位列第二。此外，在高端医疗设备中，联影医疗存在被卡脖子的经营风险。4月24日，欧盟宣布启动对中国医疗器械采购的市场准入调查。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2024-09-19/doc-incpsxxk3585278.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2024-09-19/doc-incpsxxk3585278.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1583","BK1574","09997","159883","09996","BK1222","BK1100"],"gpt_icon":0},{"id":"2468233523","title":"皖仪科技最新公告：取得医疗器械生产许可证","url":"https://stock-news.laohu8.com/highlight/detail?id=2468233523","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468233523?lang=zh_cn&edition=full","pubTime":"2024-09-19 17:10","pubTimestamp":1726737017,"startTime":"0","endTime":"0","summary":"皖仪科技公告称，公司已收到安徽省药品监督管理局颁发的《医疗器械生产许可证》，许可期限自2024年9月14日至2029年9月13日。公司将积极开展微创外科手术器械及高值耗材的市场推广，并按照相关法规、标准和产品技术要求组织生产。本次获得《医疗器械生产许可证》短期内不会对公司业绩产生重大影响，但预计对公司未来的经营将产生积极影响。目前，公司产品尚处于市场推广阶段，未形成实际销售，未来销售情况具有不确定性。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024091900026648.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09996","09997","BK1100","BK1222","BK1574","BK0225","688600","159883","BK1583"],"gpt_icon":0},{"id":"2468782955","title":"东北大哥张立国：敷尔佳“暴利之王”故事不好讲了","url":"https://stock-news.laohu8.com/highlight/detail?id=2468782955","media":"极点商业评论","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468782955?lang=zh_cn&edition=full","pubTime":"2024-09-19 16:20","pubTimestamp":1726734051,"startTime":"0","endTime":"0","summary":"敷尔佳如何以高性价比的产品回应市场需求，在产品研发上内寻突破，对东北大哥张立国来说，是必须考虑的问题了。&nbsp;&nbsp;作者|孙天宇&nbsp;编辑|杨 铭“烂脸的女生给我囤上100张敷尔佳！”2019年5月，李佳琦在直播间中大力推荐敷尔佳医用透明质酸钠修复贴，这一晚，敷尔佳以19.9元/片的价格卖出25万片。“医美面膜”标签...","market":"us","thumbnail":"https://inews.gtimg.com/om_ls/OH0WZanFEU3S70qw3eWIaf6bcRhFh52KRRQWjSXxElZQAAA_294195/0","type":0,"news_type":0,"thumbnails":["https://inews.gtimg.com/om_ls/OH0WZanFEU3S70qw3eWIaf6bcRhFh52KRRQWjSXxElZQAAA_294195/0"],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20240919A05RM400","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://new.qq.com/rain/a/20240919A05RM400","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent_tech","symbols":["BK1574","BK1222","BK1583","09997","09996","BK1100"],"gpt_icon":0},{"id":"2468083596","title":"沛嘉医疗-B(09996)下跌5.23%，报2.9元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2468083596","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468083596?lang=zh_cn&edition=full","pubTime":"2024-09-19 09:42","pubTimestamp":1726710177,"startTime":"0","endTime":"0","summary":"9月19日，沛嘉医疗-B(09996)盘中下跌5.23%，截至09:42，报2.9元/股，成交163.6万元。沛嘉医疗有限公司是一家全球医疗创新解决方案服务商，主要专注于创新、研发及生产结构性心脏病和脑血管介入领域的高端医疗器械。公司拥有在全球多个国家的创新和研发中心，覆盖了包括主动脉瓣、二尖瓣、三尖瓣及手术附件等在内的产品线，并成功打入了中国市场的数千家医院。截至2024年中报，沛嘉医疗-B营业总收入3.01亿元、净利润-7127.3万元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/09/19094243344758.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1100","BK1583","09996","159891","BK1574"],"gpt_icon":0},{"id":"2468309129","title":"新产业(300832.SZ)：获得3项医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2468309129","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468309129?lang=zh_cn&edition=full","pubTime":"2024-09-18 18:27","pubTimestamp":1726655237,"startTime":"0","endTime":"0","summary":"智通财经APP讯，新产业(300832.SZ)公告，近日，公司收到了国家药品监督管理局颁发的3项《医疗器械注册证》。产品名称分别为：乙型流行性感冒病毒IgM抗体检测试剂盒(化学发光免疫分析法)、人副流感病毒IgM抗体检测试剂盒(化学发光免疫分析法)、腺病毒IgM抗体检测试剂盒(化学发光免疫分析法)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1184170.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1100","BK1222","09996","159883","300832","BK1574","BK1583","09997","BK0239"],"gpt_icon":0},{"id":"2468519309","title":"新产业最新公告：公司获得3项医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2468519309","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468519309?lang=zh_cn&edition=full","pubTime":"2024-09-18 18:19","pubTimestamp":1726654768,"startTime":"0","endTime":"0","summary":"新产业公告，公司近日收到了国家药品监督管理局颁发的3项《医疗器械注册证》，包括乙型流行性感冒病毒IgM抗体检测试剂盒、人副流感病毒IgM抗体检测试剂盒和腺病毒IgM抗体检测试剂盒。这些产品的注册证有效期均为2024年9月12日至2029年9月11日。这些新产品的注册证取得将丰富公司化学发光检测产品中“传染病”项目类别，对公司发展具有正面影响，但对近期的生产经营和业绩不会产生重大影响。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024091800025320.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1222","BK1583","BK1574","09997","09996","159883","300832","BK0239","BK1100"],"gpt_icon":0},{"id":"2468306432","title":"圣湘生物最新公告：取得医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2468306432","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468306432?lang=zh_cn&edition=full","pubTime":"2024-09-18 18:10","pubTimestamp":1726654250,"startTime":"0","endTime":"0","summary":"圣湘生物公告，公司产品人CYP2C19基因多态性核酸检测试剂盒（PCR-荧光探针法）、人SLCO1B1基因多态性核酸检测试剂盒（PCR-荧光探针法）近日取得国家药品监督管理局颁发的《医疗器械注册证》。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024091800025151.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1574","09997","09996","BK1222","BK1583","BK0239","159883","BK1100","688289"],"gpt_icon":0},{"id":"2468303402","title":"安科生物(300009.SZ)部分产品获第一类医疗器械备案凭证","url":"https://stock-news.laohu8.com/highlight/detail?id=2468303402","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468303402?lang=zh_cn&edition=full","pubTime":"2024-09-18 17:37","pubTimestamp":1726652239,"startTime":"0","endTime":"0","summary":"智通财经APP讯，安科生物(300009.SZ)公告，公司于近日取得合肥市市场监督管理局核发的《第一类医疗器械备案编号告知书》，产品名称分别为钙荧光白染色液(CFW)及免疫显色试剂，预期用途分别为人体组织样本真菌细胞壁染色及脱落细胞染色。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1184137.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","300009","BK1222","BK1583","09997","09996","BK0060","BK0042","159883","BK1100","BK0239","BK0070"],"gpt_icon":0},{"id":"2468308833","title":"安科生物最新公告：获得第一类医疗器械备案凭证","url":"https://stock-news.laohu8.com/highlight/detail?id=2468308833","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468308833?lang=zh_cn&edition=full","pubTime":"2024-09-18 17:10","pubTimestamp":1726650626,"startTime":"0","endTime":"0","summary":"安科生物公告称，公司近日取得合肥市市场监督管理局核发的《第一类医疗器械备案编号告知书》，新产品钙荧光白染色液（CFW）和免疫显色试剂获准上市销售。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024091800024185.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK1574","BK1100","300009","09996","09997","159883","BK0060","BK1222","BK0239","BK1583","BK0042"],"gpt_icon":0},{"id":"2468725813","title":"迈克生物(300463.SZ)取得一项医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2468725813","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468725813?lang=zh_cn&edition=full","pubTime":"2024-09-18 16:29","pubTimestamp":1726648145,"startTime":"0","endTime":"0","summary":"智通财经APP讯，迈克生物(300463.SZ)公告，公司近日收到四川省药品监督管理局颁发的《医疗器械注册证(体外诊断试剂)》，产品名称为：纤溶酶原活性测定试剂盒(发色底物法)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1184079.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","300463","BK1574","BK0239","BK0012","09996","159883","BK0028","BK1222","BK0046","09997","BK1100"],"gpt_icon":0},{"id":"2468323329","title":"马斯克“脑机接口”公司新进展：“盲视”设备获FDA突破性医疗器械认证！","url":"https://stock-news.laohu8.com/highlight/detail?id=2468323329","media":"格隆汇","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468323329?lang=zh_cn&edition=full","pubTime":"2024-09-18 11:59","pubTimestamp":1726631941,"startTime":"0","endTime":"0","summary":"该设备用于帮助盲人恢复视觉重见光明。","market":"us","thumbnail":"https://img3.gelonghui.com/d77cb-699d430e-8392-4b97-9d14-ba7cab295c90.png?guru_height=316&guru_width=492","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/d77cb-699d430e-8392-4b97-9d14-ba7cab295c90.png?guru_height=316&guru_width=492"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/1057279","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["SG9999015945.SGD","LU2756315318.SGD","LU0348723411.USD","LU0689472784.USD","LU2602419157.SGD","09996","BK4581","LU0316494557.USD","09997","BK1100","BK1574","LU1548497426.USD","LU1720051108.HKD","LU2063271972.USD","BK4527","LU1551013342.USD","LU1720051017.SGD","TSLA","LU2756315664.SGD","LU1145028129.USD","BK4533","BK1583","LU2087621335.USD","LU2357305700.SGD","BK4555","LU0056508442.USD","LU1435385759.SGD","LU0820562030.AUD","LU0964807845.USD","LU1629891620.HKD","BK4548","LU0082616367.USD","IE00B1XK9C88.USD","LU0466842654.USD","LU1852331112.SGD","BK4592","LU0823414478.USD","LU1861559042.SGD","LU1551013425.SGD","BK4585","SG9999015986.USD","BK4511","LU0823411888.USD","LU0234570918.USD","LU1861558580.USD","LU2023250330.USD","LU0053666078.USD","BK1222","SG9999015978.USD","LU1429558221.USD"],"gpt_icon":1},{"id":"2468141345","title":"A股医疗器械板块盘初走低，英科医疗、阳普医疗双双跌停，冠昊生物、中红医疗、华大智造、利德曼等跌幅居前。","url":"https://stock-news.laohu8.com/highlight/detail?id=2468141345","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468141345?lang=zh_cn&edition=full","pubTime":"2024-09-18 09:34","pubTimestamp":1726623267,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["399300","300030","BK0251","300289","688114","BK1222","159982","BK1100","09997","09996","300981","BK0239","BK0046","BK0220","300677","159883","BK1574","BK0042","BK1583","BK0077","BK0146","300238","BK0028","BK0086"],"gpt_icon":0},{"id":"2468531080","title":"马斯克的脑机接口公司喜报：“盲视”已获FDA突破性医疗器械认证！","url":"https://stock-news.laohu8.com/highlight/detail?id=2468531080","media":"媒体滚动","labels":["Product Release","Policy And Regulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468531080?lang=zh_cn&edition=full","pubTime":"2024-09-18 07:59","pubTimestamp":1726617540,"startTime":"0","endTime":"0","summary":"财联社9月18日讯 马斯克的脑机接口公司Neuralink Corp.周二表示，已获得美国食品药品监督管理局对“盲视”项目的突破性医疗器械认证。据悉，该项目用于帮助盲人恢复视觉重见光明。被授予“突破性认证”的医疗设备可以更早地获得FDA的支持，从而加速其研发和市场审批过程。马斯克在X上的一篇帖子中说，这种被称为盲视的实验装置“将使那些失去双眼和视神经的人也能看到东西”。Neuralink没有立即回应有关盲视设备何时进入人体试验的详细信息。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/money/forex/forexinfo/2024-09-18/doc-incpppez2395916.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/forex/forexinfo/2024-09-18/doc-incpppez2395916.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Product Release,Policy And Regulatory","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1100","LU2602419157.SGD","LU0823411888.USD","LU1145028129.USD","09997","BK4099","LU0056508442.USD","BK4581","LU0964807845.USD","BK4588","LU2063271972.USD","LU1839511570.USD","LU1861220033.SGD","LU0719512351.SGD","IE00BWXC8680.SGD","LU2249611893.SGD","BK1222","IE00B1XK9C88.USD","LU0820561818.USD","LU2756315318.SGD","SG9999015945.SGD","SG9999015978.USD","LU0198837287.USD","LU2326559502.SGD","LU1548497426.USD","LU0943347566.SGD","BK4592","BK1574","09996","BK4574","LU0348723411.USD","BK1583","LU1861558580.USD","LU1720051108.HKD","LU1551013425.SGD","LU1861215975.USD","IE00BSNM7G36.USD","LU2357305700.SGD","LU0097036916.USD","LU2756315664.SGD","LU0234570918.USD","TSLA","BK4585","BK4551","LU0820562030.AUD","BK4527","159883","BK4550","LU0316494557.USD","LU0466842654.USD"],"gpt_icon":1},{"id":"2468310843","title":"五度易主，万东医疗颠沛流离的半生","url":"https://stock-news.laohu8.com/highlight/detail?id=2468310843","media":"医曜","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468310843?lang=zh_cn&edition=full","pubTime":"2024-09-18 07:28","pubTimestamp":1726615689,"startTime":"0","endTime":"0","summary":"在刚刚过去的财报季中，万东医疗交出了一份不错的答卷。奈何这样的业绩，仍然未能提振市场对万东医疗的信心。让所有投资者都没有想到的是，这次重组尝试仅仅是万东医疗颠沛流离的开端。一次次并购重组之间，经过五次易主的万东医疗逐渐失去了当初的光辉。02沦为资本筹码从2002年被首次收购，到2021年美的集团正式入主，万东医疗在资本市场中颠沛流离了20年。而且，万东医疗的这个主力产品销量下滑趋势非常明显。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://tech.ifeng.com/c/8cv60tqFKKo","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"ifeng_tech","symbols":["BK1222","BK1574","09997","BK1100","BK1583","09996"],"gpt_icon":0},{"id":"2468391982","title":"【马斯克脑机公司：\"盲视\"获FDA突破性医疗器械认证】金色财经报道，马斯克旗下脑机公司Neuralink表示，已获得美国食品药品监督管理局（FDA）对“盲视”（Blindsight）项目的突破性医疗器械认证。","url":"https://stock-news.laohu8.com/highlight/detail?id=2468391982","media":"金色财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468391982?lang=zh_cn&edition=full","pubTime":"2024-09-18 03:55","pubTimestamp":1726602959,"startTime":"0","endTime":"0","summary":null,"market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"'https://api.jinse.com/noah/v2/lives","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinse_live","symbols":["LU0053666078.USD","LU0943347566.SGD","LU0348723411.USD","LU1435385759.SGD","LU1629891620.HKD","IE00BJLML261.HKD","LU0316494557.USD","LU1551013342.USD","LU1852331112.SGD","SG9999015952.SGD","TSLA","BK4550","BK4099","LU0823414478.USD","SG9999015978.USD","LU2023250330.USD","IE00B1XK9C88.USD","LU2249611893.SGD","BK4511","LU0097036916.USD","LU1861559042.SGD","LU0964807845.USD","LU1548497426.USD","09997","LU0234572021.USD","BK4551","LU1551013425.SGD","LU2756315318.SGD","LU1720051017.SGD","LU2213496289.HKD","LU0082616367.USD","LU1839511570.USD","LU2357305700.SGD","LU2756315664.SGD","09996","LU0234570918.USD","BK4585","159883","LU0823411888.USD","BK4555","BK4533","BK4548","LU0820561909.HKD","LU1914381329.SGD","IE00BWXC8680.SGD","LU1861558580.USD","BK4534","IE00BSNM7G36.USD","SG9999015986.USD","LU1429558221.USD"],"gpt_icon":0},{"id":"2468396626","title":"马斯克脑机公司：\"盲视\"获FDA突破性医疗器械认证","url":"https://stock-news.laohu8.com/highlight/detail?id=2468396626","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468396626?lang=zh_cn&edition=full","pubTime":"2024-09-18 03:11","pubTimestamp":1726600278,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["LU1839511570.USD","SG9999015986.USD","BK4555","TSLA","LU0964807845.USD","LU0056508442.USD","LU2023250330.USD","LU0097036916.USD","LU2326559502.SGD","SG9999015945.SGD","LU2357305700.SGD","BK1100","BK4099","LU1861559042.SGD","LU2249611893.SGD","LU2756315318.SGD","LU1429558221.USD","LU1914381329.SGD","LU1861558580.USD","09997","09996","159883","BK4551","LU0820561909.HKD","LU1435385759.SGD","LU1551013342.USD","LU2756315664.SGD","IE00BJLML261.HKD","BK1222","LU0689472784.USD","LU1720051017.SGD","BK4550","BK4511","LU1145028129.USD","SG9999015978.USD","BK4534","LU0348723411.USD","LU0823411888.USD","LU0082616367.USD","BK4533","LU0466842654.USD","LU0820561818.USD","LU2087621335.USD","IE00B1XK9C88.USD","LU0823414478.USD","LU2063271972.USD","LU1551013425.SGD","LU0943347566.SGD","BK4585","LU2602419157.SGD"],"gpt_icon":0},{"id":"2468587747","title":"沛嘉医疗-B9月16日注销1080.9万股已回购股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2468587747","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468587747?lang=zh_cn&edition=full","pubTime":"2024-09-17 08:11","pubTimestamp":1726531879,"startTime":"0","endTime":"0","summary":"沛嘉医疗-B（09996）发布公告，该公司于2024年9月16日注销1080.9万股已回购股份。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-09-17/doc-incpmkfw9172048.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-09-17/doc-incpmkfw9172048.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_sina","symbols":["BK1574","BK1100","09996","BK1583"],"gpt_icon":0},{"id":"2468044328","title":"一家医疗器械企业终止！业绩下滑且成长性不足，科创属性遭质疑","url":"https://stock-news.laohu8.com/highlight/detail?id=2468044328","media":"IPO魔女","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468044328?lang=zh_cn&edition=full","pubTime":"2024-09-16 23:30","pubTimestamp":1726500611,"startTime":"0","endTime":"0","summary":"百多安终止原因如下：首先，2020年、2021年以及2022年1-6月百多安营业收入下滑，出现营收下滑而净利润逆势增长的情况；2021年及2022年1-6月研发费用逐年大幅下降，公司的成长性可能不足；且研发能力及科技创新能力遭交易所质疑。其次，百多安主要产品PICC销售收入占比达40%，而2022年1-6月公司PICC产能利用率仅为51%，公司...","market":"us","thumbnail":"https://inews.gtimg.com/om_ls/OkYPjE2x2jqlbp29EvnzF2eISy_q4M9gZq2Kmz3eX1sLIAA_294195/0","type":0,"news_type":0,"thumbnails":["https://inews.gtimg.com/om_ls/OkYPjE2x2jqlbp29EvnzF2eISy_q4M9gZq2Kmz3eX1sLIAA_294195/0"],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20240916A0753400","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://new.qq.com/rain/a/20240916A0753400","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent_tech","symbols":["BK1574","BK1100","09996","09997","BK1583","BK1222"],"gpt_icon":0},{"id":"2467145948","title":"沛嘉医疗-B(09996)9月16日注销1080.9万股已回购股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2467145948","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467145948?lang=zh_cn&edition=full","pubTime":"2024-09-16 20:03","pubTimestamp":1726488215,"startTime":"0","endTime":"0","summary":"智通财经APP讯，沛嘉医疗-B(09996)发布公告，该公司于2024年9月16日注销1080.9万股已回购股份。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1183651.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159891","BK1583","BK1574","09996","BK1100"],"gpt_icon":0},{"id":"2467860406","title":"沛嘉医疗-B(09996)上涨9.63%，报2.96元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2467860406","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467860406?lang=zh_cn&edition=full","pubTime":"2024-09-16 13:46","pubTimestamp":1726465605,"startTime":"0","endTime":"0","summary":"9月16日，沛嘉医疗-B(09996)盘中上涨9.63%，截至13:46，报2.96元/股，成交104.42万元。沛嘉医疗有限公司是一家全球医疗创新解决方案服务商，主要专注于创新、研发及生产结构性心脏病和脑血管介入领域的高端医疗器械。公司拥有在全球多个国家的创新和研发中心，覆盖了包括主动脉瓣、二尖瓣、三尖瓣及手术附件等在内的产品线，并成功打入了中国市场的数千家医院。截至2024年中报，沛嘉医疗-B营业总收入3.01亿元、净利润-7127.3万元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/09/16134643306362.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["09996","BK1583","BK1100","BK1574","159891"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.peijiamedical.com","stockEarnings":[{"period":"1week","weight":0.0851},{"period":"1month","weight":0.1547},{"period":"3month","weight":-0.092},{"period":"6month","weight":-0.326},{"period":"1year","weight":-0.5666},{"period":"ytd","weight":-0.5859}],"compareEarnings":[{"period":"1week","weight":0.0247},{"period":"1month","weight":0.0132},{"period":"3month","weight":-0.0418},{"period":"6month","weight":0.0473},{"period":"1year","weight":-0.0151},{"period":"ytd","weight":0.0359}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"Peijia Medical Ltd是一家主要从事介入手术医疗器械研发业务的中国控股公司。通过其子公司，该公司主要运营两个业务部门。经导管瓣膜治疗业务部门主要从事研发经导管瓣膜治疗医疗器械业务。神经介入业务部门从事研发神经介入手术医疗器械业务。该公司的主要在研产品包括TaurusOne、TaurusElite和TaurusNXT等。该公司主要在中国境内开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.087602},{"month":2,"riseRate":0.5,"avgChangeRate":0.022444},{"month":3,"riseRate":0.25,"avgChangeRate":-0.199645},{"month":4,"riseRate":0.666667,"avgChangeRate":0.038325},{"month":5,"riseRate":0.666667,"avgChangeRate":-0.097949},{"month":6,"riseRate":0.6,"avgChangeRate":0.060135},{"month":7,"riseRate":0.4,"avgChangeRate":-0.009656},{"month":8,"riseRate":0.4,"avgChangeRate":-0.07565},{"month":9,"riseRate":0.4,"avgChangeRate":0.000317},{"month":10,"riseRate":0.5,"avgChangeRate":-0.006761},{"month":11,"riseRate":0.5,"avgChangeRate":-0.006115},{"month":12,"riseRate":0.5,"avgChangeRate":0.08022}],"exchange":"SEHK","name":"沛嘉医疗-B","nameEN":"PEIJIA-B"},"APP":{"userAgent":"CCBot/2.0 (https://commoncrawl.org/faq/)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.4","shortVersion":"4.26.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"沛嘉医疗-B(09996)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供沛嘉医疗-B(09996)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"沛嘉医疗-B,09996,沛嘉医疗-B股票,沛嘉医疗-B股票老虎,沛嘉医疗-B股票老虎国际,沛嘉医疗-B行情,沛嘉医疗-B股票行情,沛嘉医疗-B股价,沛嘉医疗-B股市,沛嘉医疗-B股票价格,沛嘉医疗-B股票交易,沛嘉医疗-B股票购买,沛嘉医疗-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"沛嘉医疗-B(09996)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供沛嘉医疗-B(09996)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}